P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

• Lydia Scarfò,
• Manish R. Patel,
• Toby A. Eyre,
• Wojciech Jurczak,
• David Lewis,
• Thomas Gastinne,
• Shuo MA,
• Jonathon B. Cohen,
• Krish Patel,
• Jennifer R. Brown,
• Talha Munir,
• Ewa Lech-Maranda,
• Marc S. Hoffmann,
• Chaitra S. Ujjani,
• Bita Fakhri,
• Michael Wang,
• Koji Izutsu,
• Hirokazu Nagai,
• Constantine S. Tam,
• John F. Seymour,
• Joanna Rhodes,
• Julie Vose,
• Matthew Mckinney,
• James N. Gerson,
• Minal A. Barve,
• Bryone Kuss,
• Youngil Koh,
• Wei Gao,
• Amy S. Ruppert,
• Richard A. Walgren,
• Donald E. Tsai,
• Binoj Nair,
• Katherine Bao,
• Anthony R. Mato,
• Chan Y. Cheah,
• M Lia Palomba

Affiliations

Lydia Scarfò

1 Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy

Manish R. Patel

2 Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, United States

Toby A. Eyre

3 Churchill Cancer Center, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Wojciech Jurczak

4 Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland

David Lewis

5 Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom

Thomas Gastinne

6 Centre Hospitalier Universitaire de Nantes, Nantes, France

Shuo MA

7 Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, United States

Jonathon B. Cohen

8 Winship Cancer Institute, Emory University, Atlanta, United States

Krish Patel

9 Swedish Cancer Institute, Seattle, United States

Jennifer R. Brown

10 Dana-Farber Cancer Institute and Harvard Medical School, Boston, United States

Talha Munir

11 St. James’s University Hospital, Leeds, United Kingdom

Ewa Lech-Maranda

12 Institute of Hematology and Transfusion Medicine, Warsaw, Poland

Marc S. Hoffmann

13 The University of Kansas Cancer Center, Kansas City, United States

Chaitra S. Ujjani

14 Fred Hutchinson Cancer Center, University of Washington, Seattle, United States

Bita Fakhri

15 University of California San Francisco Medical Center, San Francisco, United States

Michael Wang

16 University of Texas, MD Anderson Cancer Center, Houston, United States

Koji Izutsu

17 National Cancer Center Hospital, Tokyo, Japan

Hirokazu Nagai

18 National Hospital Organization Nagoya Medical Center, Nagoya, Japan

Constantine S. Tam

19 Peter MacCallum Cancer Center, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia

John F. Seymour

19 Peter MacCallum Cancer Center, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia

Joanna Rhodes

20 Northwell Health Cancer Institute, New York, United States

Julie Vose

21 University of Nebraska Medical Center, Omaha, United States

Matthew Mckinney

22 Duke Cancer Institute, Durham, United States

James N. Gerson

23 Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, United States

Minal A. Barve

24 Mary Crowley Cancer Research Center, Dallas, United States

Bryone Kuss

25 Flinders University Medical Centre, Bedford Park, Australia

Youngil Koh

26 Seoul National University Hospital, Seoul, Korea, Rep. of South

Wei Gao

27 Eli Lilly and Company, Indianapolis, United States

Amy S. Ruppert

27 Eli Lilly and Company, Indianapolis, United States

Richard A. Walgren

27 Eli Lilly and Company, Indianapolis, United States

Donald E. Tsai

28 Loxo@Lilly, Indianapolis, United States

Binoj Nair

28 Loxo@Lilly, Indianapolis, United States

Katherine Bao

28 Loxo@Lilly, Indianapolis, United States

Anthony R. Mato

29 Memorial Sloan Kettering Cancer Center, New York, United States

Chan Y. Cheah

30 Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia

M Lia Palomba

29 Memorial Sloan Kettering Cancer Center, New York, United States